The Histiocytosis Program at Children’s Hospital and Vanderbilt University Medical Center offers comprehensive diagnostic, consultative and therapeutic services for children with histiocytic disorders. These disorders can affect any part of the body. They include Langerhans cell histiocytosis (LCH; also known as eosinophilic granuloma or histiocytosis X), hemophagocytic lymphohistiocytosis (HLH), Rosai-Dorfman disease (RDD; also known as sinus histiocytosis with massive lymphadenopathy), juvenile xanthogranuloma (JXG) and other less common histiocytic disorders.
Children's Hospital provides consultations for patients with newly diagnosed or recurrent histiocytosis. We also offer individualized treatment plans for patients with newly diagnosed or recurrent histiocytosis, and we participate in international clinical trials conducted by the Histiocyte Society.
We offer a personalized approach to your child’s care through the collaboration of experts from oncology, ophthalmology, orthopedics, radiation oncology, surgery, neurosurgery, nursing, child life, social work, psychology, physical and occupational therapy and nutrition.
U.S. News & World Report has ranked Children's Hospital as one of the best pediatric cancer programs in the nation.
We offer a full range of tests, treatments, and services including: